Varian unveils new Bravos afterloader system for brachytherapy treatments
Varian announced the Bravos afterloader system for High Dose Rate brachytherapy treatments. Based on over five years of in-clinic research, Bravos is an integrated system designed to improve the patient and clinic experience by simplifying brachytherapy treatment and providing greater workflow efficiency. HDR brachytherapy involves delivering radiotherapy by temporarily placing a tiny radioactive source directly into the tumor or other targeted area. Using an afterloader, clinicians are able to position the radioactive source in a needle, catheter or tumor-specific applicator following a pattern that has been designed to create a highly conformal dose distribution within or on the surface of the patient's anatomy. Once the treatment is completed, the afterloader safely returns the source to the afterloader. To simplify the treatment process, the Bravos afterloader features a touchscreen control and instinctive LED lights. The touchscreen provides easy access to patient treatment information on the afterloader, eliminating the need for the clinician to leave the room to retrieve patient and treatment information. The green, yellow and red LED lights on Bravos guide clinicians through the correct connection process of the transfer guide tubes. The green lights signal a proper connection and the yellow and red lights alert the clinician to areas needing correction. To help increase efficiency of the treatment process, Bravos features a customizable pre-treatment checklist on the touchscreen. Like surgical procedures, the customizable checklist allows the clinician to set a review process including a time-out for patient safety, and e-signatures for speed and accuracy. Bravos integrates with Varian's BrachyVision for treatment planning and offers interoperability with Varian ARIA(R) oncology information system. Bravos has received CE mark and FDA 510k clearance.